Active Retired Members (ARM)

There’s still time to stop the TPP from cutting off the critical lifeline of affordable generic medicines.

As representatives from Canada, the United States and 10 other Pacific-Rim countries gather in New Zealand Thursday to sign the Trans-Pacific Partnership (TPP) trade agreement, the fight to protect access to medicines in TPP countries is intensifying at the national level, with legislative processes starting that will determine if the deal is finally ratified and implemented.  The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is calling on the more than 800 million people living in TPP countries to urge their governments to reject the deal unless harmful provisions that lock in high drug prices are removed.

Please click on the link below to read the full article.